Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Shire Pharmaceuticals finds Adderall XR is effective in adult ADHD

Shire Pharmaceuticals finds Adderall XR is effective in adult ADHD

10th November 2005

An initial study of a drug designed to reduce adult attention deficit hyperactivity disorder (ADHD) symptoms has been successful.

Shire Pharmaceuticals found that its Adderall XR drug is effective in profoundly reducing symptoms of the condition, allowing patients to control their behaviour over long periods of time.

The study looked at 255 adult patients who took part in a four week double blind trial. Later 221 patients took part in an “open-label” trial for 24 months. Patients in the latter group were found to gain the most benefits.

It also discovered that the tolerability profile of the drug was good. Side-effects were found to generally occur in the first month of the study, reducing over the next few months. The most reported side-effects included insomnia, headache and nervousness.

“This study shows that this treatment can control the core symptoms of
ADHD for longer periods of time,” said Joseph Biederman, lead investigator in the study.

ADHD sufferers find it difficult to focus attention and suffer from bouts of hyperactivity and impulsivity. Patients often have suffered from the condition since a young age.

track© Adfero Ltd

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.